Tuesday May 14 | Freshnews
Aegis Awarded 2nd Patent for Fast Acting Migraine Nasal Spray Treatment
Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,440,631, its second patent providing fast acting formulations for triptans, a class of drugs that are effective in treating migraine headaches which include sumatriptan, zolmitriptan, naratriptan, rizatriptan, eletriptan, almotriptan and frovatriptan.
New computer chip migraine patch sends drug, electrical current into the skin
A new form of migraine therapy has been approved by the FDA. This migraine intervention comes in the form of a patch, either wrapped around the upper arm or thigh.
First Sumatriptan patch approved as migraine treatment
"The patch is an electrical skin patch," said Dr. Stewart of the Cleveland Clinic.
Migraine patch approved by FDA
There's a new weapon in the battle against migraine headache pain. An electrical skin patch provides an alternative to pills, nasal sprays and injections.
This is the first patch the FDA has approved to treat migraines
There's a new weapon in the battle against migraine headache pain. An electrical skin patch provides an alternative to pills, nasal sprays and injections.